Specialist healthcare company Admedus Ltd (ASX:AHZ), continues to advance the restructure of its global operations.
Admedus has also achieved on target sales growth, with first quarter revenue being the strongest in the history of the company.
The company has appointed Michael Walker as regional vice president, Europe and Eileen Petersen as field force optimisation manager.
Both bring global experience to Admedus and will strengthen the company’s sales focus and capabilities.
Wayne Paterson, chairman and CEO, commented: "We have turned the ship and we are now heading in the right direction in terms of sales growth and reducing expenses.
"The new appointments strengthen our global marketing capabilities, which will benefit our ADAPT® technology portfolio."
Admedus has commercialised its innovative tissue engineering technology for regenerative medicine in four continents.
Proactive Investors Australia is the market leader in producing news, articles and research reports on ASX emerging companies with distribution in Australia, UK, North America and Hong Kong / China.